Fulzerasib plus cetuximab in first-line KRAS-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
1. 系统已在2026-04-29 13:41:22对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s1470-2045(25)00764-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525007648
其他信息:
出版社: Elsevier BV
作者: Vanesa Gregorc; Margarita Majem; Giuseppe Lo Russo; Michele Maio; Stephanie Salvagni; Vanesa Gutiérrez-Calderon; Maria Gonzalez-Cao; Sergio Sandiego Contreras; Anna Koumarianou; Alessandra Bearz; Reyes Bernabé-Caro; Santiago Viteri; Miguel Fernández de Sanmamed; Flora Zagouri; Teresa Morán Bueno; Chiara Lazzari; Sergio Martínez-Recio; Ana Giménez-Capitán; Yue Zhang; Yue Shan; Huaqiang Zhu; Congqiao Zhao; Haige Shen; Yu Wang; Rafael Rosell
